Completed Enrollment

A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease (ATTAIN-J)

J2A-JE-GZPD -

The main purpose of this study is to investigate the efficacy and safety of oral orforglipron in participants with obesity disease with obesity-related health problems.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Obesity
What the trial is testing?
Orforglipron
Could I receive a Placebo?
Yes
Enrollment Goal
236
Trial Dates
Jul 31, 2023 - Jul 2025
How long will I be in the trial?
The study will last about 77 weeks and may include up to 22 visits.
Trial Phase
III

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Have obesity related health problem

  • Not be successful in losing body weight

Participants Must Not:

  • Have type 1 diabetes

  • Have a change in body weight over 5 kg (11 pounds) within 90 days prior to screening

  • Have chronic kidney disease

Lilly Trial Alerts

Sign up to receive updates about new trials and find out when a clinical trial site near you starts enrolling.

Clinical Trial Resources

Weight Management Research

To learn more about obesity, overweight and ongoing clinical trials in the area, visit our Weight Management Research page. 

Learn More

Driving Diversity in Lilly’s clinical trials

Learn how Lilly is working with health care partners to improve diversity in our clinical studies.

Watch the Video

Clinical Trial Information

A clinical trial helps us learn if a new potential medicine or treatment works and how it works. Clinical trials are also called clinical research studies. To learn more about what to expect when taking part in a clinical trial, visit our Clinical Trial Information page.